Webinar Watch - Cancer Immunotherapy Webinar: Blood Tests and Immunotherapy with Dr. Elsa Anagnostou

Webinar Watch Blood-based tests offer incredible potential in cancer immunotherapy. By monitoring a variety of factors, especially at the genetic and genomic levels, these tests can give doctors deep insights into a person’s cancer and their immune health. In this webinar, Elsa Anagnostou, M.D., Ph.D., of Johns Hopkins Medicine explains the science behind these blood tests—also known as liquid biopsies—and highlights the ways they’re being explored in clinical trials. What are liquid biopsies? Why use liquid biopsies over tissue biopsies? What is ctDNA? What exactly in ctDNA is analyzed? What are the applications of liquid biopsies? Why use liquid biopsies for immunotherapy? Do ctDNA measurements predict response to immunotherapy? Why use liquid biopsies for immunotherapy clinical trials? WATCH THE WEBINAR Dr. Elsa Anagnostou directs both the Thoracic Oncology Biorepository and the Molecular Oncology laboratory at Johns Hopkins, and is an assistant professor of oncology at the Sidney Kimmel Cancer Center. She is a CRI Clinical Accelerator Clinical Investigator at Johns Hopkins Medicine investigating whether or not blood tests for circulating tumor DNA (ctDNA) could allow for earlier detection of immunotherapy responses in people compared to current imaging technologies. The "Cancer Immunotherapy and You" Patient Education Webinar Series is produced by the Cancer Research Institute and hosted by our senior science writer, Arthur Brodsky, Ph.D. This webinar is made possible with generous support from Bristol Myers Squibb and Alkermes. The webinar series is part of the Cancer Research Institute Answer to Cancer Patient Education Program. Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other installments in this series.